22-39134042-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_175709.5(CBX7):c.605C>T(p.Ala202Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000626 in 1,598,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_175709.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBX7 | NM_175709.5 | c.605C>T | p.Ala202Val | missense_variant | 6/6 | ENST00000216133.10 | NP_783640.1 | |
CBX7 | NM_001346743.2 | c.602C>T | p.Ala201Val | missense_variant | 6/6 | NP_001333672.1 | ||
CBX7 | NM_001346744.2 | c.326C>T | p.Ala109Val | missense_variant | 6/6 | NP_001333673.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBX7 | ENST00000216133.10 | c.605C>T | p.Ala202Val | missense_variant | 6/6 | 1 | NM_175709.5 | ENSP00000216133.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000491 AC: 12AN: 244408Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132448
GnomAD4 exome AF: 0.00000622 AC: 9AN: 1446276Hom.: 0 Cov.: 31 AF XY: 0.00000279 AC XY: 2AN XY: 717462
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.605C>T (p.A202V) alteration is located in exon 6 (coding exon 6) of the CBX7 gene. This alteration results from a C to T substitution at nucleotide position 605, causing the alanine (A) at amino acid position 202 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at